Alto Neuroscience (ANRO) Other Non-Current Assets (2024 - 2026)
Alto Neuroscience's (ANRO) quarterly Other Non-Current Assets came in at $500000.0 in Q1 2026, little changed year-on-year from $500000.0 in Q1 2025, and up 47.93% quarter-over-quarter from $338000.0 in Q4 2025.
Alto Neuroscience (ANRO) Other Non-Current Assets (2024 - 2026) Analysis & Trends
Alto Neuroscience has disclosed Other Non-Current Assets across 3 years of filings, most recently posting $500000.0 for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $500000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $500000.0 (changed 0.0% YoY), and the FY2025 annual result was $338000.0, down 32.4% from the prior year.
- Other Non-Current Assets came in at $500000.0 for Q1 2026 at Alto Neuroscience, up from $338000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $570000.0 in Q2 2025 to a low of $4000.0 in Q2 2024.
- The 3-year median for Other Non-Current Assets is $500000.0 (2024), against an average of $385555.6.
- Peak annual rise in Other Non-Current Assets reached 14150.0% in 2025, while the deepest fall reached 32.4% in 2025.
- Alto Neuroscience's Other Non-Current Assets stood at $500000.0 in 2024, then tumbled by 32.4% to $338000.0 in 2025, then jumped by 47.93% to $500000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $500000.0 (Q1 2026), $338000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Alto Neuroscience | 643.06 Mn | 379.30 Mn | - | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 338,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 570,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 58,000.00 |